HLA-DQ6 and ingestion of contaminated water: Possible gene-environment interaction in an outbreak of leptospirosis

Genes and Immunity

Volumn 5, Issue 3, 2004, Pages 197-202

  Lingappa, J ^a   Kuffner, T ^a   Tappero, J ^a   Whitworth, W ^a   Mize, A ^a   Kaiser, R ^a   McNicholl, J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Gene environment interaction; HLA; Human leukocyte antigen; Leptospirosis; Outbreak investigation; Superantigen

Indexed keywords

GENOMIC DNA; HLA DQ ANTIGEN; LAKE WATER; SUPERANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EPIDEMIC; FEMALE; FLUID INTAKE; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; LABORATORY DIAGNOSIS; LEPTOSPIROSIS; MALE; MEDICAL DOCUMENTATION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TRIATHLON; WATER CONTAMINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; COHORT STUDIES; DISEASE OUTBREAKS; DNA; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS; MALE; MIDDLE AGED; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WATER MICROBIOLOGY; WATER SUPPLY;

EID: 3242747467     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364058     Document Type: Article

References (52)

1. Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14: 296-326.
2. Tappero JW, Ashford DA, Perkins BA. Leptospirosis. In: Mandell G, Bennett J, Dolan R (eds). Principles and Practice of Infectious Diseases. Churchill Livingstone: New York, 1999, pp 2495-2501.
3. Zaki S, Spiegel RA. Leptospirosis. In: Nelson AM, Horsburgh Jr CR (eds). Pathology of Emerging Infections Vol 2 American Society for Microbiology: Washington, DC, 1998, pp 73-92.
4. Demers RY, Thiermann A, Demers P, Frank R. Exposure to Leptospira icterohaemorrhagiae in inner-city and suburban children: a serologic comparison. J Fam Pract 1983; 17: 1007-1011.
5. Cacciapuoti B, Vellucci A, Ciceroni L, Pinto A, Taggi F. Prevalence of leptospirosis in man. Pilot survey. Eur J Epidemiol 1987; 3: 137-142.
6. Childs JE, Schwartz BS, Ksiazek TG, Graham RR, LeDuc JW, Glass GE. Risk factors associated with antibodies to leptospires in inner-city residents of Baltimore: a protective role for cats. Am J Public Health 1992; 82: 597-599.
7. Ashford DA, Kaiser RM, Spiegel RA et al. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg 2000; 63: 249-254.
8. Trevejo RT, Rigau-Perez JG, Ashford DA et al. Epidemic leptospirosis associated with pulmonary hemorrhage - Nicaragua, 1995. J Infect Dis 1998; 178: 1457-1463.
9. Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Leptospirosis in Barbados. A clinical study. W Indian Med J 1990; 39: 27-34.
10. Berman SJ, Tsai CC, Holmes K, Fresh JW, Watten RH. Sporadic anicteric leptospirosis in South Vietnam. A study in 150 patients. Ann Intern Med 1973; 7: 167-173.
11. Alexander AD, Benenson AS, Byrne RJ et al. Leptospirosis in Puerto Rico. Zoonoses Res. 1963; 2: 152-227.
12. Tajiki H, Salomao R. Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 1996; 23: 1177-1178.
13. Hill AV. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet 2001; 2: 373-400.
14. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16: 593-617.
15. Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990; 323: 219-223.
16. Morgan J, Bornstein SL, Karpati AM et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 2002; 34: 1593-1599.
17. Guarner J, Shieh WJ, Morgan J et al. Leptospirosis mimicking acute cholecystitis among athletes participating in a triathlon. Hum Pathol 2001; 32: 750-752.
18. Crawford RP, Heinemann JM, McCulloch WF, Diesch SL. Human infections associated with waterborne Leptospires, and survival studies on serotype pomona. J Am Vet Med Assoc 1971; 159: 1477-1484.
19. Cacciapuoti B, Ciceroni L, Maffei C et al. A waterborne outbreak of leptospirosis. Am J Epidemiol 1987; 126: 535-545.
20. Corwin A, Ryan A, Bloys W, Thomas R, Deniega B, Watts D. A waterborne outbreak of leptospirosis among United States military personnel in Okinawa, Japan. Int J Epidemiol 1990; 19: 743-748.
21. Centers for Disease Control Prevention. Outbreak of leptospirosis among Whitewater Rafters, Costa Rica, 1996. Morbidity and Mortality Weekly Reports 1997; 46: 577-579.
22. Centers for Disease Control Prevention. Update: Outbreak of acute febrile illness among participants in EcoChallenge Sabah 2000 - Malaysia, 2000. Morbidity and Mortality Weekly Reports 2000; 50: 21-24.
23. Sarkar U, Nascimento SF, Barbosa R et al. Population-based case-control investigation of risk factors for leptospirosis during an urban epidemic. Am J Trop Med Hyg 2002; 66: 605-610.
24. Ambrosone CB, Freudenheim JL, Graham S et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996; 276: 1494-1501.
25. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 2001; 153: 1016-1020.
26. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
27. Shaw GM, Wasserman CR, Lammer EJ et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 1996; 58: 551-561.
28. Hwang SJ, Beaty TH, Panny SR et al. Association study of transforming growth factor alpha (TGF alpha) TaqI polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 1995; 141: 629-636.
29. Cheng TJ, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol Biomarkers Prey 1995; 4: 535-542.
30. Ghaderi M, Nikitina L, Peacock CS et al. Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden. Cancer Epidemiol Biomarkers Prev 2000; 9: 1067-1070.
31. Beck HP, Felger I, Barker M et al. Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population. Am J Trop Med Hyg 1995; 53: 284-288.
32. Hill AV, Allsopp CE, Kwiatkowski D et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600.
33. Goldfeld AE, Delgado JC, Thim S et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279: 226-228.
34. Singh SP, Mehra NK, Dingley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 1983; 148: 676-681.
35. Sriram U, Selvaraj P, Kurian SM, Reetha AM, Narayanan PR. HLA-DR2 subtypes & immune responses in pulmonary tuberculosis. Indian J Med Res 2001; 113: 117-124.
36. Carrington M, Nelson G, O'Brien SJ. Considering genetic profiles in functional studies of immune responsiveness to HIV-1. Immunol Lett 2001; 79: 131-140.
37. Hill AV. HIV and HLA: confusion or complexity? Nat Med 1996; 2: 395-396.
38. Kaslow RA, Rivers C, Tang J et al. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J Virol 2001; 75: 8681-8689.
39. Krausa P, McAdam S, Bunce M et al. HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan population. Exp Clin Immunogenet 1999; 16: 17-25.
40. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296: 1439-1443.
41. McNicholl JM, Cuenco KT. Host genes and infectious diseases. HIV, other pathogens, and a public health perspective. Am J Prev Med 1999; 16: 141-154.
42. Steere AC, Sikand VK, Meurice F et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 1998; 339: 209-215.
43. Sato AK, Sturniolo T, Sinigaglia F, Stern LJ. Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303). Hum Immunol 1999; 60: 1227-1236.
44. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002; 2: 156-162.
45. Schlievert PM, Bohach GA, Ohlendorf DH et al. Molecular structure of staphylococcus and streptococcus superantigens. J Clin Immunol 1995; 15 (Suppl): 4S-10S.
46. Leung DY, Meissner HC, Fulton DR, Quimby F, Schlievert PM. Superantigens in Kawasaki syndrome. Clin Immunol Immunopathol 1995; 77: 119-126.
47. Kline JB, Collins CM. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun 1996; 64: 861-869.
48. Sundberg E, Jardetzky TS. Structural basis for HLA-DQ binding by the streptococcal superantigen SSA. Nat Struct Biol 1999; 6: 123-129.
49. Sriskandan S, Unnikrishnan M, Krausz T et al. Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J Infect Dis 2001; 184: 166-173.
50. Yeung RS, Penninger JM, Kundig T et al. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur J Immunol 1996; 26: 1074-1082.
51. Arad G, Levy R, Kaempfer R. Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re-exposure to superantigen. Immunol Lett 2002; 82: 75-78.
52. Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000; 30: 3247-3255.